Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
$514.48
-0.8%
$523.12
$356.14
$549.52
$41.37B1.54642,795 shs133,137 shs
Moody's Corporation stock logo
MCO
Moody's
$498.51
-0.8%
$486.33
$378.71
$531.93
$89.89B1.38762,889 shs461,630 shs
Envista Holdings Corporation stock logo
NVST
Envista
$19.38
-1.9%
$18.87
$14.22
$23.00
$3.29B12.46 million shs675,743 shs
Zoetis Inc. stock logo
ZTS
Zoetis
$147.97
-1.0%
$161.00
$139.70
$200.33
$65.82B0.912.61 million shs1.16 million shs
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for July 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
-0.36%-4.14%-0.36%+25.98%+4.48%
Moody's Corporation stock logo
MCO
Moody's
+0.49%-0.60%+6.77%+18.49%+10.27%
Envista Holdings Corporation stock logo
NVST
Envista
+0.36%-4.53%+7.22%+30.18%+15.08%
Zoetis Inc. stock logo
ZTS
Zoetis
-0.96%-5.55%-7.20%+0.91%-17.61%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
3.6744 of 5 stars
1.43.00.03.74.02.51.3
Moody's Corporation stock logo
MCO
Moody's
4.5816 of 5 stars
2.35.03.33.22.22.51.3
Envista Holdings Corporation stock logo
NVST
Envista
3.3812 of 5 stars
2.21.00.03.83.30.01.9
Zoetis Inc. stock logo
ZTS
Zoetis
4.8833 of 5 stars
3.55.04.20.43.12.51.9
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
2.80
Moderate Buy$560.338.91% Upside
Moody's Corporation stock logo
MCO
Moody's
2.53
Moderate Buy$519.074.12% Upside
Envista Holdings Corporation stock logo
NVST
Envista
2.33
Hold$20.234.41% Upside
Zoetis Inc. stock logo
ZTS
Zoetis
2.70
Moderate Buy$204.6338.29% Upside

Current Analyst Ratings Breakdown

Latest IDXX, MCO, NVST, and ZTS Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/17/2025
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
Leerink Partners
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$580.00 ➝ $600.00
7/17/2025
Zoetis Inc. stock logo
ZTS
Zoetis
Leerink Partnrs
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeStrong-Buy ➝ Hold
7/17/2025
Zoetis Inc. stock logo
ZTS
Zoetis
Leerink Partners
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOutperform ➝ Market Perform$180.00 ➝ $155.00
7/9/2025
Envista Holdings Corporation stock logo
NVST
Envista
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$19.00 ➝ $23.00
7/8/2025
Moody's Corporation stock logo
MCO
Moody's
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$445.00 ➝ $515.00
7/7/2025
Moody's Corporation stock logo
MCO
Moody's
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$493.00 ➝ $498.00
7/3/2025
Moody's Corporation stock logo
MCO
Moody's
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$572.00 ➝ $573.00
7/2/2025
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetHold ➝ Hold$510.00 ➝ $540.00
7/2/2025
Moody's Corporation stock logo
MCO
Moody's
Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$523.00 ➝ $552.00
7/1/2025
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$625.00
6/18/2025
Zoetis Inc. stock logo
ZTS
Zoetis
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Hold$165.00 ➝ $160.00
(Data available from 7/18/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
$3.90B10.62$12.28 per share41.88$19.48 per share26.41
Moody's Corporation stock logo
MCO
Moody's
$7.09B12.65$14.90 per share33.45$20.57 per share24.23
Envista Holdings Corporation stock logo
NVST
Envista
$2.51B1.31$1.63 per share11.87$17.05 per share1.14
Zoetis Inc. stock logo
ZTS
Zoetis
$9.26B7.12$6.90 per share21.43$10.57 per share14.00
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
$887.87M$10.8247.5437.883.8022.76%57.35%26.97%8/4/2025 (Confirmed)
Moody's Corporation stock logo
MCO
Moody's
$2.06B$11.5843.1531.963.1029.15%60.37%15.33%7/23/2025 (Estimated)
Envista Holdings Corporation stock logo
NVST
Envista
-$1.12B-$6.53N/A16.011.25-44.90%4.07%2.25%7/31/2025 (Estimated)
Zoetis Inc. stock logo
ZTS
Zoetis
$2.49B$5.5726.5421.922.5127.12%55.48%19.14%8/5/2025 (Estimated)

Latest IDXX, MCO, NVST, and ZTS Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/5/2025Q2 2025
Zoetis Inc. stock logo
ZTS
Zoetis
$1.61N/AN/AN/A$2.41 billionN/A
8/4/2025Q2 2025
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
$3.28N/AN/AN/A$1.06 billionN/A
7/31/2025Q2 2025
Envista Holdings Corporation stock logo
NVST
Envista
$0.24N/AN/AN/A$638.21 millionN/A
7/23/2025Q2 2025
Moody's Corporation stock logo
MCO
Moody's
$3.30N/AN/AN/A$1.82 billionN/A
5/6/2025Q1 2025
Zoetis Inc. stock logo
ZTS
Zoetis
$1.40$1.48+$0.08$1.41$2.20 billion$2.22 billion
5/1/2025Q1 2025
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
$2.93$2.96+$0.03$2.96$998.25 million$998.43 million
5/1/2025Q1 2025
Envista Holdings Corporation stock logo
NVST
Envista
$0.20$0.24+$0.04$0.10$608.17 million$616.90 million
4/22/2025Q1 2025
Moody's Corporation stock logo
MCO
Moody's
$3.58$3.83+$0.25$3.46$1.90 billion$1.92 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
N/AN/AN/AN/AN/A
Moody's Corporation stock logo
MCO
Moody's
$3.760.75%N/A32.47%16 Years
Envista Holdings Corporation stock logo
NVST
Envista
N/AN/AN/AN/AN/A
Zoetis Inc. stock logo
ZTS
Zoetis
$2.001.35%N/A35.91%14 Years

Latest IDXX, MCO, NVST, and ZTS Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/22/2025
Zoetis Inc. stock logo
ZTS
Zoetis
quarterly$0.501.2%7/18/20257/18/20259/3/2025
4/23/2025
Moody's Corporation stock logo
MCO
Moody's
quarterly$0.940.9%5/16/20255/16/20256/6/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
0.31
1.16
0.81
Moody's Corporation stock logo
MCO
Moody's
1.77
1.57
1.56
Envista Holdings Corporation stock logo
NVST
Envista
0.43
2.12
1.82
Zoetis Inc. stock logo
ZTS
Zoetis
1.12
1.74
1.04

Institutional Ownership

CompanyInstitutional Ownership
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
87.84%
Moody's Corporation stock logo
MCO
Moody's
92.11%
Envista Holdings Corporation stock logo
NVST
Envista
N/A
Zoetis Inc. stock logo
ZTS
Zoetis
92.80%

Insider Ownership

CompanyInsider Ownership
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
0.98%
Moody's Corporation stock logo
MCO
Moody's
0.14%
Envista Holdings Corporation stock logo
NVST
Envista
1.30%
Zoetis Inc. stock logo
ZTS
Zoetis
0.18%
CompanyEmployeesShares OutstandingFree FloatOptionable
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
11,00080.42 million79.63 millionOptionable
Moody's Corporation stock logo
MCO
Moody's
15,838179.90 million179.65 millionOptionable
Envista Holdings Corporation stock logo
NVST
Envista
12,300169.49 million167.28 millionOptionable
Zoetis Inc. stock logo
ZTS
Zoetis
13,800445.21 million444.41 millionOptionable

Recent News About These Companies

Cwm LLC Purchases 4,282 Shares of Zoetis Inc. (NYSE:ZTS)
Here's Why Zoetis (ZTS) is a Strong Growth Stock
Zoetis: Global Leader In Animal Healthcare

New MarketBeat Followers Over Time

Media Sentiment Over Time

IDEXX Laboratories stock logo

IDEXX Laboratories NASDAQ:IDXX

$514.48 -4.24 (-0.82%)
As of 12:37 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

IDEXX Laboratories, Inc. develops, manufactures, and distributes products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets in Africa, the Asia Pacific, Canada, Europe, Latin America, and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It also provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory diagnostic instruments, and services for biomedical research community. In addition, the company offers diagnostic and health-monitoring products for livestock, poultry, and dairy; products that test water for various microbiological contaminants; point-of-care electrolytes and blood gas analyzers; in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, and coagulation analyzers; and SNAP rapid assays test kits. Further, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; and veterinary software and services for independent veterinary clinics and corporate groups. Additionally, the company offers human medical point-of-care products and laboratory diagnostics services. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.

Moody's stock logo

Moody's NYSE:MCO

$498.51 -3.92 (-0.78%)
As of 12:37 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Moody's Corporation operates as an integrated risk assessment firm worldwide. It operates in two segments, Moody's Analytics and Moody's Investors Services. The Moody's Analytics segment develops a range of products and services that support the risk management activities of institutional participants in financial markets. It also offers credit research, credit models and analytics, economics data and models, and structured finance solutions; data sets on companies and securities; and SaaS solutions supporting banking, insurance, and know your customer workflows. The Moody's Investors Service segment publishes credit ratings and provides assessment services on various debt obligations, programs and facilities, and entities that issue such obligations, such as various corporate, financial institution, and governmental obligations, as well as structured finance securities. The company was formerly known as Dun and Bradstreet Company and changed its name to Moody's Corporation in September 2000. Moody's Corporation was founded in 1900 and is headquartered in New York, New York.

Envista stock logo

Envista NYSE:NVST

$19.38 -0.37 (-1.89%)
As of 12:36 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products. This segment also provides software packages, which include DTX Studio Implant; DTX Studio Lab; and DTX Studio Clinic, a software package offered with its imaging products. It offers its products under the Nobel Biocare, Alpha-Bio Tec, Implant Direct, Nobel Procera, Ormco, Spark, Orascoptic, Damon, Insignia, AOA brands. The Equipment & Consumables segment provides dental equipment and supplies, including digital imaging systems, software, and other visualization/magnification systems; endodontic systems and related products; restorative materials, rotary burs, impression materials, bonding agents, and cements; and infection prevention products. This segment offers its products under the Dexis, DTX Studio, Kerr, Metrex, Total Care, Pentron, Optibond, Harmonize, Sonicfill, Sybron Endo, and CaviWipes to dental offices, clinics, and hospitals. Envista Holdings Corporation was incorporated in 2018 and is headquartered in Brea, California.

Zoetis stock logo

Zoetis NYSE:ZTS

$147.96 -1.57 (-1.05%)
As of 12:37 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.